Pfizer Nears Deal to Combine Off-Patent Drug Unit With Mylan
Pfizer Inc. signage is displayed on a monitor on the floor of the New York Stock Exchange. (Photographer: Michael Nagle/Bloomberg)

Pfizer Nears Deal to Combine Off-Patent Drug Unit With Mylan

(Bloomberg) -- Pfizer Inc. plans to combine its off-patent business, which includes Lipitor cholesterol pills and male-impotence drug Viagra, with Mylan NV and form a generic drug giant, according ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.